Pregnancy outcome following first trimester exposure to sumatriptan

S. Shuhaiber; A. Pastuszak; B. Schick; D. Matsui; G. Spivey; J. Brochu; Gideon Koren

doi:10.1212/WNL.51.2.581

Pregnancy outcome following first trimester exposure to sumatriptan

S. Shuhaiber, A. Pastuszak, B. Schick, D. Matsui, G. Spivey, J. Brochu, Gideon Koren

Research output: Contribution to journal › Article › peer-review

76 Scopus citations

Abstract

We prospectively compared pregnancy outcome after exposure to sumatriptan with that of disease-matched controls and nonteratogen controls. There were no differences in the rates of live births, spontaneous abortions, therapeutic abortions, or major birth defects among the three groups. This first prospective report suggests that the use of sumatriptan during organogenesis is not associated with an apparent increased risk of major birth defects.

Original language	English
Pages (from-to)	581-583
Number of pages	3
Journal	Neurology
Volume	51
Issue number	2
DOIs	https://doi.org/10.1212/WNL.51.2.581
State	Published - Aug 1998
Externally published	Yes

Access to Document

10.1212/WNL.51.2.581

Cite this

@article{d96de283f9d64cd8b26142222bd416c4,

title = "Pregnancy outcome following first trimester exposure to sumatriptan",

abstract = "We prospectively compared pregnancy outcome after exposure to sumatriptan with that of disease-matched controls and nonteratogen controls. There were no differences in the rates of live births, spontaneous abortions, therapeutic abortions, or major birth defects among the three groups. This first prospective report suggests that the use of sumatriptan during organogenesis is not associated with an apparent increased risk of major birth defects.",

author = "S. Shuhaiber and A. Pastuszak and B. Schick and D. Matsui and G. Spivey and J. Brochu and Gideon Koren",

year = "1998",

month = aug,

doi = "10.1212/WNL.51.2.581",

language = "אנגלית",

volume = "51",

pages = "581--583",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Pregnancy outcome following first trimester exposure to sumatriptan

AU - Shuhaiber, S.

AU - Pastuszak, A.

AU - Schick, B.

AU - Matsui, D.

AU - Spivey, G.

AU - Brochu, J.

AU - Koren, Gideon

PY - 1998/8

Y1 - 1998/8

N2 - We prospectively compared pregnancy outcome after exposure to sumatriptan with that of disease-matched controls and nonteratogen controls. There were no differences in the rates of live births, spontaneous abortions, therapeutic abortions, or major birth defects among the three groups. This first prospective report suggests that the use of sumatriptan during organogenesis is not associated with an apparent increased risk of major birth defects.

AB - We prospectively compared pregnancy outcome after exposure to sumatriptan with that of disease-matched controls and nonteratogen controls. There were no differences in the rates of live births, spontaneous abortions, therapeutic abortions, or major birth defects among the three groups. This first prospective report suggests that the use of sumatriptan during organogenesis is not associated with an apparent increased risk of major birth defects.

UR - http://www.scopus.com/inward/record.url?scp=0031781404&partnerID=8YFLogxK

U2 - 10.1212/WNL.51.2.581

DO - 10.1212/WNL.51.2.581

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 9710039

AN - SCOPUS:0031781404

SN - 0028-3878

VL - 51

SP - 581

EP - 583

JO - Neurology

JF - Neurology

IS - 2

ER -

Pregnancy outcome following first trimester exposure to sumatriptan

Abstract

Access to Document

Other files and links

Fingerprint

Cite this